<TABLE> <S> <C>
<S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
FOR THE PERIOD ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
<MULTIPLIER> 1,000
<S> <C> <C>
<PERIOD-TYPE> 6-MOS <F1>
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUL-01-2000
<CASH> 175
<SECURITIES> 0
<RECEIVABLES> 1,451 <F2>
<ALLOWANCES> 0
<INVENTORY> 368
<CURRENT-ASSETS> 3,162
<PP&E> 2,156 <F2>
<DEPRECIATION> 0
<TOTAL-ASSETS> 8,831
<CURRENT-LIABILITIES> 6,723
<BONDS> 0
0
11,886
<COMMON> 135
<OTHER-SE> 1,973
<TOTAL-LIABILITY-AND-EQUITY> 8,831
<SALES> 5,240
<TOTAL-REVENUES> 10,154
<CGS> 3,753
<TOTAL-COSTS> 7,226
<OTHER-EXPENSES> 2,524 <F3>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 234
<INCOME-PRETAX> (7,926)
<INCOME-TAX> 15
<INCOME-CONTINUING> (7,941)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (7,941)
<EPS-BASIC> (0.93) <F4>
<EPS-DILUTED> (0.93)
<FN>
<F1> The 26-week period from January 1, 2000 to July 1, 2000 is referred to
herein as the six months ended June 30, 2000.
<F2> Item shown net of allowance, consistent with the balance sheet
presentation.
<F3> Item consists of research and development.
<F4> Item consists of basic earnings per share.
</FN>
</TABLE>
